Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and

E Raichlin1, H R Villarraga, K Chandrasekaran

  • 1Division of Cardiology, William J. Von Liebig Transplant Center, Mayo Clinic, Rochester, MN, USA.

Insights

Left ventricular remodeling is common after heart transplantation (HTX), with abnormal geometry seen in 85% of patients early on. Concentric hypertrophy at 1 year predicts increased mortality and graft arteriosclerosis.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Cardiac Imaging

Background:

  • Left ventricular remodeling (LVR) is a significant concern following heart transplantation (HTX).
  • Understanding LVR patterns, predictors, and outcomes is crucial for improving graft survival and patient prognosis.

Purpose of the Study:

  • To investigate the temporal patterns of left ventricular geometry after HTX.
  • To identify predictors of left ventricular remodeling.
  • To evaluate the impact of LVR on mortality and graft arteriosclerosis.

Main Methods:

  • Echocardiographic studies analyzed in 134 HTX recipients at 1 week, 1 year, and 3-5 years post-transplant.
  • Patients categorized into normal geometry (NG), concentric remodeling (CR), and concentric hypertrophy (CH) groups.
  • Statistical analysis to determine predictors and outcomes associated with LVR.

Main Results:

  • Abnormal left ventricular geometry was present in 85% of patients by 1 week post-HTX.
  • Explosive donor brain death predicted early concentric hypertrophy (CH).
  • CH at 1 week, elevated BMI, and cytomegalovirus viremia predicted 1-year CH.
  • 1-year CH was linked to increased mortality (RR 1.87) and graft arteriosclerosis (RR 2.04).
  • 1-year CR also associated with increased graft arteriosclerosis (RR 1.73).

Conclusions:

  • Left ventricular remodeling is prevalent and occurs early after heart transplantation.
  • Specific donor and recipient factors predict the development of concentric hypertrophy.
  • Concentric remodeling and hypertrophy of the cardiac allograft are associated with adverse long-term outcomes, including mortality and graft arteriosclerosis.

Related Concept Videos